SUPPLY ARRANGEMENT - LABORATORY ANALYSIS OF RAW MATERIALS AND FINISHED PRODUCTS (Stream 1,2 and,3)

Tender summary

The objective of the project is to have tests carried out in accordance with Good Manufacturing Practices and current regulations (Health Canada, Food and Drug Administration (FDA), European Medicines Agency (EMA) for the analysis of raw materials, solutions, products, etc., in order to confirm the quality of our products. The National Research Council of Canada has built a new Clinical Trial Material Facility (CTMF) that will house the process and equipment for the production and the quality control of protein, viral vector or virus- like particle vaccines or biologics. The facility will require being compliant with Canadian Good Manufacturing Practices (GMP) as well as FDA current GMP (cGMP) and Eudralex requirements. This supply Arrangement includes 3 Streams (1,2,3) of services as follows: Stream 1 – Raw Material Analysis , Stream 2 – Various solutions, Biological products Analysis and Stream 3 – Cell Bank Characterization . See Statement of work for full details.

What to check before bidding

• Issued by National Research Council of Canada (NRC).
• Located in Canada.
• Source notice cb-939-143225 on CanadaBuys.
• Notice published 11 Feb 2026; Tenqual indexed it 12 Feb 2026.
• Deadline listed as 24 Mar 2026.
• Create a free tender alert to catch similar opportunities before the deadline pressure starts.